These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 17905536

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
    Citron DM, Babakhani F, Goldstein EJ, Nagaro K, Sambol S, Sears P, Shue YK, Gerding DN.
    Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
    [Abstract] [Full Text] [Related]

  • 6. Antibacterial activity of teicoplanin against Clostridium difficile.
    Wongwanich S, Kusum M, Phan-Urai R.
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):606-9. PubMed ID: 9185278
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic resistance of Clostridium difficile isolates.
    Dworczyński A, Sokół B, Meisel-Mikołajczyk F.
    Cytobios; 1991 Sep; 65(262-263):149-53. PubMed ID: 1828756
    [Abstract] [Full Text] [Related]

  • 8. [Antimicrobial susceptibility of Clostridium difficile clinical isolates collected from 2001 to 2007 in a French university hospital].
    Cattoir V, Ould-Hocine ZF, Legrand P.
    Pathol Biol (Paris); 2008 Sep; 56(7-8):407-11. PubMed ID: 18845403
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparative evaluation of e-test and disk diffusion methods for susceptibility testing of Nocardia species].
    Perçin D, Sümerkan B, Inci R.
    Mikrobiyol Bul; 2011 Apr; 45(2):274-9. PubMed ID: 21644070
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.
    Tyrrell KL, Citron DM, Warren YA, Fernandez HT, Merriam CV, Goldstein EJ.
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2728-31. PubMed ID: 16870765
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.
    Zheng L, Citron DM, Genheimer CW, Sigmon SF, Carman RJ, Lyerly DM, Goldstein EJ.
    Anaerobe; 2007 Aug; 13(3-4):114-20. PubMed ID: 17531516
    [Abstract] [Full Text] [Related]

  • 19. [Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes].
    Rokosz A, Sawicka-Grzelak A, Kot K, Meszaros J, Łuczak M.
    Med Dosw Mikrobiol; 2001 Aug; 53(2):167-75. PubMed ID: 11757426
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.